- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 17/16 - Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms containing two or more hetero rings
Patent holdings for IPC class C12P 17/16
Total number of patents in this class: 388
10-year publication summary
|
17
|
26
|
27
|
33
|
25
|
37
|
21
|
31
|
32
|
18
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Codexis, Inc. | 818 |
31 |
| The Regents of the University of California | 20590 |
15 |
| Genentech, Inc. | 4090 |
10 |
| Hypha Discovery Limited | 16 |
8 |
| East China University of Science and Technology | 545 |
7 |
| Biosyntia ApS | 15 |
6 |
| Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 46 |
6 |
| Kiverdi, Inc. | 65 |
6 |
| Pro Farm Group, Inc. | 124 |
6 |
| Ludwig Institute for Cancer Research Ltd | 194 |
5 |
| Victoria Link Limited | 190 |
5 |
| DSM IP Assets B.V. | 5422 |
4 |
| University of Florida Research Foundation, Inc. | 4159 |
4 |
| Danmarks Tekniske Universitet | 1021 |
4 |
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 294 |
4 |
| Colorifix Limited | 13 |
4 |
| F. Hoffmann-La Roche AG | 7847 |
3 |
| AstraZeneca AB | 2830 |
3 |
| Novozymes A/S | 3361 |
3 |
| Georgia Tech Research Corporation | 2912 |
3 |
| Other owners | 251 |